Anders Ljungberg

476 total citations
11 papers, 343 citations indexed

About

Anders Ljungberg is a scholar working on Dermatology, Immunology and Epidemiology. According to data from OpenAlex, Anders Ljungberg has authored 11 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Dermatology, 5 papers in Immunology and 2 papers in Epidemiology. Recurrent topics in Anders Ljungberg's work include Psoriasis: Treatment and Pathogenesis (5 papers), Dermatology and Skin Diseases (5 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Anders Ljungberg is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (5 papers), Dermatology and Skin Diseases (5 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Anders Ljungberg collaborates with scholars based in Sweden, Denmark and Finland. Anders Ljungberg's co-authors include Ӧlle Johansson, Lotus Mallbris, Per Larsson, Annikki Vaalasti, Mari‐Anne Hedblad, Ola Ghatnekar, Hanna Tainio, O. Johansson, Åke Svensson and Mark Lebwohl and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

Anders Ljungberg

11 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Ljungberg Sweden 8 191 118 93 58 42 11 343
Maryte Papadopoulos United States 10 132 0.7× 426 3.6× 172 1.8× 68 1.2× 19 0.5× 14 625
Neil J. Korman United States 6 77 0.4× 103 0.9× 143 1.5× 116 2.0× 86 2.0× 8 459
Sebastian D. Vulcu Germany 7 167 0.9× 108 0.9× 123 1.3× 19 0.3× 15 0.4× 10 320
T. Talme Sweden 8 75 0.4× 54 0.5× 29 0.3× 23 0.4× 31 0.7× 14 209
Jenny Dave United States 6 153 0.8× 32 0.3× 59 0.6× 81 1.4× 25 0.6× 17 328
Florentino Sánchez-García Spain 11 79 0.4× 37 0.3× 115 1.2× 49 0.8× 30 0.7× 24 281
Yuka Kubota Japan 8 30 0.2× 83 0.7× 38 0.4× 13 0.2× 13 0.3× 22 307
Gea Kõks Estonia 10 93 0.5× 46 0.4× 57 0.6× 18 0.3× 30 0.7× 15 367
Giovanni Luigi Capella Italy 10 59 0.3× 132 1.1× 36 0.4× 34 0.6× 48 1.1× 39 309
Mamori Tani Japan 13 94 0.5× 286 2.4× 75 0.8× 79 1.4× 93 2.2× 30 462

Countries citing papers authored by Anders Ljungberg

Since Specialization
Citations

This map shows the geographic impact of Anders Ljungberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Ljungberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Ljungberg more than expected).

Fields of papers citing papers by Anders Ljungberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Ljungberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Ljungberg. The network helps show where Anders Ljungberg may publish in the future.

Co-authorship network of co-authors of Anders Ljungberg

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Ljungberg. A scholar is included among the top collaborators of Anders Ljungberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Ljungberg. Anders Ljungberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Strober, Bruce, Craig L. Leonardi, Kim Papp, et al.. (2016). Short- and long-term safety outcomes with ixekizumab from 7 clinical trials in psoriasis: Etanercept comparisons and integrated data. Journal of the American Academy of Dermatology. 76(3). 432–440.e17. 98 indexed citations
3.
Ljungberg, Anders, et al.. (2013). [Psoriasis is more than just a skin disease. Patients should be monitored for cardiovascular risk factor].. PubMed. 110(41). 1796–8. 1 indexed citations
4.
Ghatnekar, Ola, et al.. (2012). Costs and quality of life for psoriatic patients at different degrees of severity in southern Sweden – a cross-sectional study. European Journal of Dermatology. 22(2). 238–245. 29 indexed citations
5.
Ghatnekar, Ola, et al.. (2010). PSS6 COST OF ILLNESS OF PSORIASIS—A 1-MONTH PROSPECTIVE STUDY IN SOUTHERN SWEDEN. Value in Health. 13(7). A398–A398. 2 indexed citations
6.
Kerkhof, P.C.M. van de, et al.. (2007). Psoriasis of the face and flexures. Journal of Dermatological Treatment. 18(6). 351–360. 27 indexed citations
7.
Mallbris, Lotus, et al.. (2003). Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-? therapy. Journal of the American Academy of Dermatology. 48(2). 290–293. 67 indexed citations
8.
Nordlind, K., et al.. (1995). Immunohistochemical Localization of Interleukin‐6—like Immunoreactivity to Peripheral Nerve‐like Structures in Normal and Inflamed Human Skin. Annals of the New York Academy of Sciences. 762(1). 450–451. 5 indexed citations
9.
Ljungberg, Anders & Ӧlle Johansson. (1993). Methodological aspects on immunohistochemistry in dermatology with special reference to neuronal markers. The Histochemical Journal. 25(10). 735–745. 34 indexed citations
10.
Vaalasti, Annikki, et al.. (1990). Evidence for γ-Melanocyte Stimulating Hormone Containing Nerves and Neutrophilic Granulocytes in the Human Skin by Indirect Immunofluorescence. Journal of Investigative Dermatology. 96(6). 852–856. 24 indexed citations
11.
Johansson, O., Annikki Vaalasti, Hanna Tainio, & Anders Ljungberg. (1988). Immunohistochemical evidence of galanin in sensory nerves of human digital skin. Acta Physiologica Scandinavica. 132(2). 261–263. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026